Maternal Perception of Infant Sleep and Bonding in Opioid Use Disorder

2024-9-11

Two Clinical Insights on Methamphetamine Withdrawal at a Safety-Net Hospital

2024-9-4

Medications for Alcohol Use Disorder among Birthing People with an Alcohol-related Diagnosis

2024-9-4

Naloxone Stigma Among People Who Use Drugs: Characteristics and Associations With Stigma Toward Medication for Opioid Use Disorder

2024-9-4

Response to “Two Clinical Insights on Methamphetamine Withdrawal at a Safety-Net Hospital”

2024-9-4

A Pharmacologic Evaluation of Buprenorphine in Pregnancy and the Postpartum Period

2024-9-2

Improving Estimates of the Prevalence of Opioid Use Disorder in the United States: Revising Keyes et al

2024-9-2

Cannabinoid Hyperemesis Syndrome Presumed Secondary to CBD Use: A Case Report

2024-9-2

Perinatal Naloxone Care Practices: Survey Results From Persons With OUD and Providers

2024-9-2

Distinct Trajectories of Prescription Opioid Exposure in Pregnancy and Risk of Adverse Birth Outcomes

2024-9-2

Expert Panel Consensus on the Effectiveness and Implementation of Models to Support Posthospitalization Care Transitions for People With Substance Use Disorders

2024-9-2

Barriers and Facilitators to Accessing Opioid Agonist Therapy for Street-involved Adolescents and Young Adults in Vancouver

2024-8-27

Induction to Methadone 80 mg in the First Week of Treatment of Patients Who Use Fentanyl: A Case Series From an Outpatient Opioid Treatment Program

2024-8-16

Supervised Disulfiram Should Be Considered First-Line Treatment for Alcohol Use Disorder

2024-8-16

Medications for Opioid Use Disorder after Entering Residential Treatment: Evidence from Louisiana Medicaid

2024-8-16

Disulfiram Should Remain Second-line Treatment for Most Patients with Alcohol Use Disorder

2024-8-16

A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-Associated Liver Disease

2024-8-16

Treatment Failure Versus Failed Treatments: The Risks of Embracing Treatment Refractory Addiction

2024-8-12

The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review

2024-8-12

Revisiting Preaddiction

2024-8-12

Readmissions among Patients with Surgically Managed Drug Use Associated-Infective Endocarditis before and after the Implementation of an Addiction Consult Team: A Retrospective, Observational Analysis

2024-8-12

Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool in Screening Older Adults for Unhealthy Substance Use

2024-8-12

The Concept of Treatment-Refractory Addiction: Implications for Addiction Treatment Systems and Research

2024-8-12

The Concept of Treatment-Refractory Addiction: A Call to the Field

2024-8-12

An Intervention to Improve Evidence-Based Nicotine Prescribing by Primary Care Physicians

2024-8-12

Association between Smoking Abstinence and Depression and Anxiety Symptoms After Hospital Discharge: The Helping HAND 4 Trial

2024-8-8

Trauma Prevalence and Its Association With Health-Related Quality of Life in Pregnant Persons with Opioid Use Disorder

2024-8-6

Off-Label Use of Lamotrigine and Naltrexone in the Treatment of Ketamine Use Disorder: A Case Report

2024-8-5

The Impact of COVID-19 on Substance Use and Related Consequences among Patients in Office-Based Opioid Use Disorder Treatment

2024-8-5

The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients

2024-8-2

Experience Starting an Addiction Medicine Practice-Based Research Network

2024-7-30

Age-related Psychometric Dimensionality Using the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition Opioid Use Disorder Diagnostic Criteria

2024-7-23

Malignant Catatonia in the Setting of Acute Methamphetamine and Cocaine Intoxication

2024-7-23

Wound Care Capacity of the Addiction Workforce in the Setting of Xylazine

2024-7-23

A Source Control Model for Treatment-Resistant Substance Use Disorder

2024-7-16

Trend in Prescription Medication Utilization for Opioid Use Disorder and Alcohol Use Disorder From 2015 to 2021: A Population-wide Study in a Canadian Province

2024-7-16

Use of Cannabinoids by People Who Consume Kratom in the United States

2024-7-16

Diagnosis and Treatment of Presumed Naltrexone-XR–precipitated Opioid Withdrawal in a Patient Chronically Treated With Buprenorphine-XR: A Case Report

2024-7-5

Jenna’s Project: Preventing Overdose and Improving Recovery Outcomes for Women Leaving Incarcerated Settings during Pregnancy and Postpartum Periods

2024-7-3

Addressing Confusion and Inconsistencies Surrounding the Provider Role in Medical Cannabis Programs

2024-7-1

Low Risk of Cardiac Complications during Long-Term Follow-Up of Opioid Dependence

2024-6-27

Treating Benzodiazepine Withdrawal in a Bridge Clinic

2024-6-26

The Pharmacological Management of Ketamine Use Disorder: A Systematic Review

2024-6-26

Naloxone Use During Pregnancy—Data from 26 US Jurisdictions, 2019–2020

2024-6-24

Standard Versus Rapid Inpatient Methadone Titration for Pregnant Patients With Opioid Use Disorder: A Retrospective Cohort Study

2024-6-24

Examining the Impact of the Innovative Opioid Court Model on Treatment Access and Court Outcomes for Court Participants

2024-6-24

Early Surgical Excision of Necrotic Tissue Following Unintentional Dermal Injection of Extended-Release Buprenorphine

2024-6-13

Integration of a Community Opioid Treatment Program into a Federally Qualified Health Center

2024-6-13

Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations

2024-6-13

Receipt of Medications for Alcohol Use Disorder in the Veterans Health Administration: Comparison of Rates at the Intersections of Racialized and Ethnic Identity With Both Sex and Transgender Status

2024-6-6